BrainAurora Medical Technology Limited (HKG:6681)
3.820
+0.040 (1.06%)
Apr 29, 2026, 4:08 PM HKT
HKG:6681 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | - | -198.28 | -359.08 | -502.45 | -697.84 |
| Depreciation & Amortization | - | 26.27 | 21 | 12.36 | 1.55 |
| Other Amortization | - | 0.88 | 0.27 | 0.07 | 0.08 |
| Loss (Gain) From Sale of Assets | - | -0 | 0.06 | 0.13 | -0.01 |
| Loss (Gain) From Sale of Investments | - | -0.01 | -2.67 | -3.24 | - |
| Stock-Based Compensation | - | 66.77 | 44.87 | - | 19.37 |
| Provision & Write-off of Bad Debts | - | 11.48 | 0.85 | 0.05 | 0.01 |
| Other Operating Activities | - | -14.27 | 183.54 | 401.2 | 628.83 |
| Change in Accounts Receivable | - | -64.45 | -48.01 | -11.79 | -6.01 |
| Change in Accounts Payable | - | 12.33 | 23.44 | 2.07 | 4.85 |
| Change in Unearned Revenue | - | 9.68 | 2.71 | 0.72 | 0.39 |
| Change in Other Net Operating Assets | - | 3.56 | -3.84 | 0.21 | -0.44 |
| Operating Cash Flow | - | -146.04 | -136.87 | -100.68 | -49.21 |
| Capital Expenditures | - | -17.33 | -15.97 | -16.4 | -10.8 |
| Sale of Property, Plant & Equipment | - | 0.07 | 0.25 | 0.02 | 0.01 |
| Sale (Purchase) of Intangibles | - | -0.37 | -2.05 | -2.66 | -0.02 |
| Investment in Securities | - | 0.01 | 333.46 | -327.55 | - |
| Other Investing Activities | - | 144.91 | -212.64 | 2.63 | -1.17 |
| Investing Cash Flow | - | 123.38 | 102.55 | -334.46 | -21.48 |
| Short-Term Debt Issued | - | 335.04 | 15 | 6.96 | - |
| Long-Term Debt Issued | - | - | - | 50 | 350 |
| Total Debt Issued | - | 335.04 | 15 | 56.96 | 350 |
| Short-Term Debt Repaid | - | -15 | -2.36 | - | -4.09 |
| Long-Term Debt Repaid | - | -8.26 | -7.95 | -6.25 | -0.81 |
| Total Debt Repaid | - | -23.26 | -10.31 | -6.25 | -4.89 |
| Net Debt Issued (Repaid) | - | 311.78 | 4.69 | 50.71 | 345.11 |
| Issuance of Common Stock | - | - | 153.12 | 89.5 | 63.7 |
| Other Financing Activities | - | -2.98 | -94.28 | -0.57 | -15.19 |
| Financing Cash Flow | - | 308.81 | 63.53 | 139.65 | 393.61 |
| Foreign Exchange Rate Adjustments | - | 0.16 | 0.12 | 0.01 | - |
| Net Cash Flow | - | 286.31 | 29.33 | -295.49 | 322.93 |
| Free Cash Flow | - | -163.37 | -152.84 | -117.08 | -60.01 |
| Free Cash Flow Margin | - | -133.57% | -227.44% | -1036.94% | -2610.05% |
| Free Cash Flow Per Share | - | -0.16 | -0.26 | -0.42 | -0.40 |
| Cash Interest Paid | - | 1.02 | 0.63 | 0.57 | 0.19 |
| Cash Income Tax Paid | - | 0.05 | - | - | - |
| Levered Free Cash Flow | - | 8.4 | -252.93 | -82.34 | - |
| Unlevered Free Cash Flow | - | 22.17 | -240.29 | -70.32 | - |
| Change in Working Capital | - | -38.88 | -25.71 | -8.8 | -1.2 |
Source: S&P Capital IQ. Standard template. Financial Sources.